According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.738359. At the end of 2023 the company had a P/S ratio of 0.7486.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.7486 | 10.31% |
2022 | 0.6786 | 21.96% |
2021 | 0.5564 | -10.99% |
2020 | 0.6251 | 0.6% |
2019 | 0.6214 | -30.94% |
2018 | 0.8998 | 4.53% |
2017 | 0.8608 | -48.75% |
2016 | 1.68 | -44.21% |
2015 | 3.01 | 25.69% |
2014 | 2.40 | 44.02% |
2013 | 1.66 | 6.12% |
2012 | 1.57 | -19.45% |
2011 | 1.95 | -32.94% |
2010 | 2.90 | -18.91% |
2009 | 3.58 | 4.86% |
2008 | 3.41 | -14.5% |
2007 | 3.99 | 36.18% |
2006 | 2.93 | -44.66% |
2005 | 5.30 | 35.81% |
2004 | 3.90 | -18.84% |
2003 | 4.81 | 21.21% |
2002 | 3.97 | 4.34% |
2001 | 3.80 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | 3.81 | 415.93% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 2.40 | 224.58% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2.37 | 220.39% | ๐ซ๐ท France |
![]() Merck MRK | 4.54 | 514.66% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 4.41 | 497.26% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | 2.05 | 177.07% | ๐ฌ๐ง UK |
![]() Dr. Reddy's RDY | 3.59 | 386.32% | ๐ฎ๐ณ India |